Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Conditions:   Hepatocellular Carcinoma;   Liver Transplantation Intervention:   Drug: relenvatinib group Sponsor:   RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

This article presents a comprehensive review of current knowledge regarding the posttransplant management of patients with hepatocellular carcinoma.American Journal of Transplantation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news
Publication date: May 2020Source: Microbial Pathogenesis, Volume 142Author(s): Saleha Resham, Muhammad Saalim, Sobia Manzoor, Hassam Ahmad, Tariq Ali Bangash, Amer Latif, Shahla Jaleel
Source: Microbial Pathogenesis - Category: Infectious Diseases Source Type: research
AJ Gunn, M.D. graduated magna cum laude from Brigham Young University in Provo, UT, earning a BS in exercise physiology with a minor in sociology. He then returned home to South Dakota to attend medical school at the University of South Dakota. During medical school, he participated in the competitive Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program and was awarded the Donald L. Alcott, M.D. Award for Clinical Promise. He graduated summa cum laude in 2009. He completed his diagnostic radiology residency at the Massachusetts General Hospital of Harvard Medical School in Boston,...
Source: radRounds - Category: Radiology Authors: Source Type: blogs
Publication date: March 2020Source: Journal of Vascular and Interventional Radiology, Volume 31, Issue 3, SupplementAuthor(s): Y. Wang, K. Schachtschneider, Y. Huang, R. Gaba, P. Nguyen, P. Yen, M. Sverdlov, G. Guzman, R. Lokken
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research
AJ Gunn, M.D. graduated magna cum laude from Brigham Young University in Provo, UT, earning a BS in exercise physiology with a minor in sociology. He then returned home to South Dakota to attend medical school at the University of South Dakota. During medical school, he participated in the competitive Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program and was awarded the Donald L. Alcott, M.D. Award for Clinical Promise. He graduated summa cum laude in 2009. He completed his diagnostic radiology residency at the Massachusetts General Hospital of Harvard Medical School in Boston,...
Source: radRounds - Category: Radiology Authors: Source Type: blogs
Tc-99m macro-aggregated albumin (MAA) imaging to estimate hepato-pulmonary shunting (LSF) is required prior to radioembolization (Y90) to mitigate risks of radiation pneumonitis. We hypothesize that patients with hepatocellular carcinoma (HCC) within Milan criteria for liver transplant have negligible LSF. This would potentially allow eliminating MAA studies when treating this cohort of HCC patients with Y90.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 3 Source Type: research
To assess the role of pretreatment tumor radiomic features in predicting pathologic response in patients with hepatocellular carcinoma (HCC) listed for liver transplant.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 4 Source Type: research
To describe survival data of elderly patients with hepatocellular carcinoma (HCC) treated with loco-regional therapy (LRT) and to compare the survival outcomes of “transplantable” LRT patients with patients with HCC outside the criteria for liver transplantation (LT).
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 25 Source Type: research
Despite curative intent of liver transplant (LT), hepatocellular carcinoma (HCC) recurs in 15% of patients. Recurrence is confined to the liver in
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 15 Source Type: research
To evaluate the pathologic findings in liver explants of patients with hepatocellular carcinoma (HCC) who received radiation segmentectomy.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 15 Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver | Liver Cancer | Liver Transplant | Research | Transplants | Urology & Nephrology